Upregulated CCL20 expression has been observed under conditions of hepatic fibrosis in patients with chronic liver diseases, such as hepatitis C virus infection, alcoholic steatohepatitis or primary biliary cirrhosis [10] and in patients with MASH [42]. The gene discussed is CCL20; the disease is metabolic dysfunction-associated steatohepatitis.